sanjoy.Logosanjoy.Logosanjoy.Logosanjoy.Logo
  • Home
  • Courses
  • About
  • Consultation
  • Notes on Medicine
  • Blog
  • Contact
  • Login
Make an Appointment
✕

Hypertension in pregnancy 

  • Home
  • Notes on Medicine
  • Chapter 32: Maternal Medicine Hypertension in pregnancy
  • Hypertension in pregnancy 

Hypertension in pregnancy 

Hypertension in pregnancy 

on 15 Jan, 2025
  • Date15 Jan, 2025

SAQ. In the third trimester, a pregnant woman develops jaundice, thought to be caused by antihypertensive drugs.

  1. Which is the most likely drug that may cause jaundice? What is the mechanism 
  • Likely drug: Alpha methyldopa

Mechanism of Hepatotoxicity: 

  • Autoimmune mechanism
  • Metabolic studies suggest that methyldopa may induce an autoimmune liver injury (perhaps via a toxic metabolic intermediate serving as an antigenic hapten presented on the surface of hepatocytes) in susceptible hosts.

 

  1. How will you investigate to support your diagnosis?

 

Investigations : 

The acute liver injury within 2 -12 weeks of starting therapy.

 

Investigations  Interpretation 
  1. ALT, AST
  2. ALP
  3. S. Bilirubin 
  1. Marked elevations (5-100 folds) 
  2. Modest increases
  3. increased
HBsAg, anti HCV, 

anti HAV, anti HEV

  • To exclude viral hepatitis
ANA, Coombs test
  • To exclude autoimmune disease
Liver biopsy 
  • marked inflammatory infiltrates,  fatty change, variable amounts of necrosis.

 

Management of hypertension in pregnancy:

Non- pharmacological

  • Regular exercise may be continued
  • For obese women: advised to avoid weight gain of more than 6-8 kg

 

Pharmacological:

  • Drugs of choice (Contraindicated: ACEI, ARB, Diuretics)
    • Methyldopa
    • Beta blockers (Labetalol)
    • CCB (Nifedipine, amlodipine)
    • Doxazosin

  • Prevention of HTN and pre-eclampsia:
  • High or moderate risk of pre-eclampsia: 100-150 mg of Aspirin daily from week 12 to weeks 36-37 of pregnancy
  • Calcium supplementation: 1.5-2 gm/day is recommended for prevention of pre-eclampsia in women with low dietary intake of calcium (<600 mg/day), to be commenced at the first antenatal clinic.

 

  • For prevention & Rx of eclampsia: IV MgSO4 (but not with CCB)

  • Rx of severe HTN
  • Hospitalization is indicated 
  • Anti-HTN drug & route of administration depends on expected time of delivery
  • IV Labetalol/oral Methyldopa/Nifedipine should be initiated
  • Na-nitroprusside is the drug of last choice, due to risk of fetal cyanide poisoning
  • Preeclampsia associated with pulmonary oedema: nitroglycerine IV infusion
  • Delivery: Indicated in 
  1. Pre-eclampsia with visual disturbances or hemostatic disorders
  2. At 37 weeks in asymptomatic woman

 

Preeclampsia:

  • Control of blood pressure, 
  • IV magnesium sulfate as prophylaxis against seizures.
  • Correction of coagulation abnormalities 
  • Monitoring of fluid balance. 
  • If these measures are ineffective and eclampsia supervenes  
    • urgent delivery 

 

Eclampsia 

  • It usually presents with seizures on a background of pre-eclampsia but rarely can occur before the onset of hypertension and proteinuria. 
  • Treatment: 
    • Anti hypertensives
    • IV magnesium sulfate (Inf. Nalepsin 4 gm/100 ml) 4 g, over 15 mins followed by an infusion of 1 g/hr titrated to serum magnesium for 24 h. 
    • Correction of coagulation abnormalities.
    • Monitoring of fluid balance. 
    • Delivery of the fetus as soon as possible. 

 

Prognosis:

  • Women with pre-eclampsia are more likely to develop HTN, CKD, IHD, cerebrovascular in later life.
Share
0

Topics

  • Chapter 04: Clinical Immunology (4)
    • Cryoglobulin (1)
    • Hereditary angioedema (1)
    • Monoclonal antibody (Mab) (1)
    • Primary Immune Deficiency (1)
  • Chapter 05: Population health & Epidemiology (2)
    • Case control Vs Cohort study (1)
    • Screening tools / test (1)
  • Chapter 06: Principles of Infectious Diseases (1)
    • Antimicrobial stewardship (AMS) (1)
  • Chapter 07: Oncology (9)
    • A. Breaking Bad News (1)
    • B. Investigation in cancer patient (1)
    • C. CUP / MUO (1)
    • D. Neutropenic fever (1)
    • E. Hypercalcemia in malignancy (1)
    • F. Immune-related adverse events (IRAE) (1)
    • G. Tumor lysis syndrome (1)
    • H. Malignant pleural effusion (1)
    • I. Systemic anti-cancer therapy (SACT) (1)
  • Chapter 08: Palliative - ethical issue (4)
    • Informed written consent (1)
    • Non medical issue (1)
    • Pain management (1)
    • Palliative care (1)
  • Chapter 09: Acute Medicine (8)
    • ARDS (1)
    • Coma (1)
    • How to write an ICU discharge summary (1)
    • ICU-acquired weakness (1)
    • OSPE/IOE (1)
    • Rhabdomyolysis (1)
    • Sepsis (1)
    • Ventilator-induced lung injury (VILI) (1)
  • Chapter 10: Poisoning (6)
    • A. Poisoning by pharmaceutical agent (0)
    • B. drugs of misuse. (0)
    • C. Poisoning by chemical and pesticides (6)
      • 1. Carbon monoxide (CO) poisoning (1)
      • 2. OPC Poisoning (1)
      • 3. Paraquat Poisoning (1)
      • 4. Ethanol intoxication (acute alcohol consumption) (1)
      • 5. Chronic Lead poisoning (1)
      • 6. Gas tablet poisoning (1)
    • D. Environmental poisoning (0)
    • E. Food related poisoning (0)
  • Chapter 11: Envenomation (0)
  • Chapter 12: Environmental Medicine (6)
    • Drowning (1)
    • Frostbite (1)
    • Heat stroke (1)
    • High Altitude illness (1)
    • Hypothermia (1)
    • Immersion (1)
  • Chapter 18: Nephrology (6)
    • 01. Investigation (1)
    • 02. Clinical Presentation (3)
      • (A). Polyuria (1)
      • (B). Haematuria (1)
      • (C). Proteinuria (1)
    • 03. Glomerular Disease (2)
      • IgA Nephropathy (1)
      • RPGN (1)
    • 10. Infection of Urinary Tract (0)
    • 4. Tubulo-interstitial Diseases (0)
    • 5. Genetic Renal Diseases (0)
    • 6. Renovascular Diseases (0)
    • 7. Acute Kidney Injury (AKI) (0)
    • 8. Chronic Kidney Disease (CKD) (0)
    • 9. Renal Replacement Therapy (RRT) (0)
  • Chapter 19: Clinical Biochemistry and Metabolic medicine (1)
    • Potassium Homeostasis (1)
      • Hyperkalaemia (0)
      • Hypokalaemia (1)
  • Chapter 20: Endocrinology (19)
    • Adrenal Gland Diseases (6)
      • Adrenal insufficiency (1)
      • Congenital Adrenal Hyperplasia (CAH) (1)
      • Cushing Syndrome (1)
      • Pheochromocytoma (1)
      • Primary hyperaldosteronism (1)
      • Steroid withdrawal or tapering (1)
    • Autoimmune Polyendocrine Syndrome(APS) (0)
    • Endocrine Pancreas (0)
    • Hypothalamo-pituitary Disease (0)
    • Multiple Endocrine Neoplasia (MEN) (0)
    • Others (0)
    • Parathyroid Disorder (2)
      • Hyperparathyroidism (1)
      • Pseudohypoparathyroidism (1)
    • Reproductive Endocrinology (6)
      • Delayed puberty / Hypogonadism (1)
      • Hirsutism (1)
      • Hyperprolactinemia (1)
      • Klinefelter syndrome (1)
      • PCOS (1)
      • Turner’s syndrome (1)
    • Thyroid Disorder (5)
      • Graves' Disease (1)
      • Hypothyroidism (0)
      • Subclinical Hypothyroidism (1)
      • Subclinical Thyrotoxicosis (1)
      • Thyroid Lump or Swelling (1)
      • Thyrotoxicosis (1)
  • Chapter 22: Nutritional factors in disease (4)
    • Intestinal Failure (1)
    • Refeeding Syndrome (1)
    • Vitamin deficiency or excess (2)
      • Scurvy (1)
      • Vit B3 (Niacin) deficiency: Plegra (1)
  • Chapter 23: Gastroenterology (15)
    • Colon and Rectum (0)
    • Esophagus (3)
      • Achalasia of the esophagus (1)
      • Dysphagia (1)
      • GERD (1)
    • Pancreas (0)
    • Small Gut (9)
      • A. Coeliac disease (1)
      • B. Small intestinal bacterial overgrowth (SIBO) (1)
      • C. Whipple disease (1)
      • D. Bile acid diarrhea (1)
      • E. Radiation enteropathy (1)
      • F. Protein-losing enteropathy (1)
      • G. Eosinophilic gastroenteritis (1)
      • H. Lactose intolerance (0)
      • I. IPSID (1)
      • J. IBS (1)
    • Stomch (3)
      • Gastric carcinoma (1)
      • Peptic ulcer disease - PUD (1)
      • Zollinger Ellison syndrome (ZES) (1)
  • Chapter 24: Hepatology (2)
    • Inherited Liver Disease (2)
      • Hemochromatosis (1)
      • Wilson disease (1)
  • Chapter 25: Hematology (1)
    • Anemia (1)
      • Microcytic Hypochromic Anemia (MHA) (1)
        • Iron Deficiency Anemia (IDA) (1)
  • Chapter 26: Rheumatology (3)
    • Autoimmune connective tissue disease (0)
      • Polymyositis & Dermatomyositis (0)
    • Disease of Bone (2)
      • Hypertropic Osteoarthropathy (1)
      • Osteonecrosis/ Avascular necrosis (AVN) (1)
    • Vasculitis (1)
      • Small vessel vasulitis (1)
  • Chapter 27: Dermatology (1)
    • Skin disease in general medicine (1)
      • Reactive disorder (1)
        • Erythema nodosum (1)
  • Chapter 32: Maternal Medicine (8)
    • CVST in Pregnancy (1)
    • Diabetes in pregnancy (1)
    • Epilepsy in Pregnancy (1)
    • Hypertension in pregnancy (1)
    • Liver disease in pregnancy (1)
    • Psychiatric Illness in Pregnancy (1)
    • Thromboembolism (1)
    • Thyroid Disease in Pregnancy (1)
      • Hyperthyroidism in Pregnancy (1)
      • Hypothyroidism in Pregnancy (0)
  • Chapter 34: Ageing (7)
    • Delirium (1)
    • Fall (1)
    • Frailty (1)
    • Geriatric giants (1)
    • MDT (1)
    • Prescribing & deprescribing (1)
    • Urinary Incontinence (1)
  • My AMC Part 1 Notes (0)
    • Obstetrics (0)
      • CTG (0)

Subscribe Our Newsletter

Get Every Update

Please enable JavaScript in your browser to complete this form.
Loading

Serving the humanity.

Important Links

  • Home
  • About
  • Consultation
  • Blog
  • Contact
  • Privacy Policy

Services

  • Chamber (Offline) Consultation
  • Video (Online) Consultation
  • Notes On Medicine
  • Free Advice

Location

DSR Diagnostic, Hariavanga Bazar, Assasuni, Satkhira

Contact

drsanjoyray23@gmail.com

mobile: +88 01974417704

Copy@2023 Dr. Sanjoy. All Right Reserved.
    • No translations available for this page